CHEMOURS ($CC) is expected to release its quarterly earnings data on Thursday, November 6th after market close, per Finnhub. Analysts are expecting revenue of $1,543,069,481 and earnings of $0.26 per share.
You can see Quiver Quantitative's $CC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CHEMOURS Insider Trading Activity
CHEMOURS insiders have traded $CC stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CC stock by insiders over the last 6 months:
- DAMIAN GUMPEL (See Remarks) has made 2 purchases buying 21,222 shares for an estimated $201,376 and 0 sales.
- SHANE HOSTETTER (Chief Financial Officer) purchased 4,450 shares for an estimated $50,196
- DENISE DIGNAM (President & CEO) purchased 4,068 shares for an estimated $49,060
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CHEMOURS Hedge Fund Activity
We have seen 219 institutional investors add shares of CHEMOURS stock to their portfolio, and 163 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 10,766,097 shares (-67.7%) from their portfolio in Q2 2025, for an estimated $123,271,810
- BLACKROCK, INC. added 4,309,136 shares (+19.9%) to their portfolio in Q2 2025, for an estimated $49,339,607
- MARSHALL WACE, LLP removed 3,452,586 shares (-57.9%) from their portfolio in Q2 2025, for an estimated $39,532,109
- MILLENNIUM MANAGEMENT LLC added 3,387,377 shares (+84.2%) to their portfolio in Q2 2025, for an estimated $38,785,466
- JPMORGAN CHASE & CO removed 2,145,222 shares (-38.8%) from their portfolio in Q2 2025, for an estimated $24,562,791
- NORGES BANK removed 1,763,524 shares (-97.1%) from their portfolio in Q2 2025, for an estimated $20,192,349
- KHROM CAPITAL MANAGEMENT LLC removed 1,427,489 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $16,344,749
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CHEMOURS Analyst Ratings
Wall Street analysts have issued reports on $CC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 10/16/2025
- Truist Securities issued a "Buy" rating on 09/16/2025
- RBC Capital issued a "Outperform" rating on 07/03/2025
To track analyst ratings and price targets for CHEMOURS, check out Quiver Quantitative's $CC forecast page.
CHEMOURS Price Targets
Multiple analysts have issued price targets for $CC recently. We have seen 7 analysts offer price targets for $CC in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $18.0 on 10/16/2025
- Joshua Spector from UBS set a target price of $21.0 on 10/06/2025
- Peter Osterland from Truist Securities set a target price of $21.0 on 09/16/2025
- Arun Viswanathan from RBC Capital set a target price of $15.0 on 07/03/2025
- Michael Leithead from Barclays set a target price of $13.0 on 05/28/2025
- Duffy Fischer from Goldman Sachs set a target price of $14.0 on 05/14/2025
- Vincent Andrews from Morgan Stanley set a target price of $15.0 on 05/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
